HEADER BIOSYNTHETIC PROTEIN 02-NOV-07 2ZC3 TITLE PENICILLIN-BINDING PROTEIN 2X (PBP 2X) ACYL-ENZYME COMPLEX (BIAPENEM) TITLE 2 FROM STREPTOCOCCUS PNEUMONIAE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PENICILLIN-BINDING PROTEIN 2X; COMPND 3 CHAIN: A, D; COMPND 4 FRAGMENT: UNP RESIDUES 71-238; COMPND 5 SYNONYM: PBP-2X, PBP2X; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: N-TERMINAL DOMAIN; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: PENICILLIN-BINDING PROTEIN 2X; COMPND 10 CHAIN: B, E; COMPND 11 FRAGMENT: UNP RESIDUES 241-625; COMPND 12 SYNONYM: PBP-2X, PBP2X; COMPND 13 ENGINEERED: YES; COMPND 14 OTHER_DETAILS: TRANSPEPTIDASE DOMAIN; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: PENICILLIN-BINDING PROTEIN 2X; COMPND 17 CHAIN: C, F; COMPND 18 FRAGMENT: UNP RESIDUES 626-750; COMPND 19 SYNONYM: PBP-2X, PBP2X; COMPND 20 ENGINEERED: YES; COMPND 21 OTHER_DETAILS: C-TERMINAL DOMAIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOCOCCUS PNEUMONIAE; SOURCE 3 GENE: PBPX; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 6 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: STREPTOCOCCUS PNEUMONIAE; SOURCE 9 GENE: PBPX; SOURCE 10 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 13 MOL_ID: 3; SOURCE 14 ORGANISM_SCIENTIFIC: STREPTOCOCCUS PNEUMONIAE; SOURCE 15 GENE: PBPX; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS PEPTIDOGLYCAN SYNTHESIS, CELL WALL, PENICILLIN-BINDING, ANTIBIOTICS, KEYWDS 2 BIAPENEM, ANTIBIOTIC RESISTANCE, CELL CYCLE, CELL DIVISION, CELL KEYWDS 3 SHAPE, CELL WALL BIOGENESIS/DEGRADATION, MEMBRANE, SECRETED, KEYWDS 4 TRANSMEMBRANE, BIOSYNTHETIC PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.YAMADA,T.WATANABE,Y.TAKEUCHI REVDAT 4 01-NOV-23 2ZC3 1 COMPND REMARK HETNAM LINK REVDAT 3 24-FEB-09 2ZC3 1 VERSN REVDAT 2 03-JUN-08 2ZC3 1 JRNL REVDAT 1 08-APR-08 2ZC3 0 JRNL AUTH M.YAMADA,T.WATANABE,N.BABA,Y.TAKEUCHI,F.OHSAWA,S.GOMI JRNL TITL CRYSTAL STRUCTURES OF BIAPENEM AND TEBIPENEM COMPLEXED WITH JRNL TITL 2 PENICILLIN-BINDING PROTEINS 2X AND 1A FROM STREPTOCOCCUS JRNL TITL 3 PNEUMONIAE JRNL REF ANTIMICROB.AGENTS CHEMOTHER. V. 52 2053 2008 JRNL REFN ISSN 0066-4804 JRNL PMID 18391040 JRNL DOI 10.1128/AAC.01456-07 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.51 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 93.3 REMARK 3 NUMBER OF REFLECTIONS : 50660 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.237 REMARK 3 R VALUE (WORKING SET) : 0.235 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2691 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.56 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3837 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.04 REMARK 3 BIN R VALUE (WORKING SET) : 0.3050 REMARK 3 BIN FREE R VALUE SET COUNT : 196 REMARK 3 BIN FREE R VALUE : 0.3850 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9881 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 53 REMARK 3 SOLVENT ATOMS : 82 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 52.76 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.99 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.86000 REMARK 3 B22 (A**2) : -3.53000 REMARK 3 B33 (A**2) : 0.67000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.594 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.326 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.248 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.417 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.928 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.893 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 10111 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 13697 ; 0.960 ; 1.968 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1278 ; 5.257 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 448 ;39.593 ;25.826 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1746 ;14.657 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 36 ;14.089 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1547 ; 0.065 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7614 ; 0.002 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 4257 ; 0.180 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 7020 ; 0.293 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 331 ; 0.126 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 70 ; 0.131 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 7 ; 0.083 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 6567 ; 0.370 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 10283 ; 0.662 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 4010 ; 0.602 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3414 ; 1.037 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2ZC3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 05-NOV-07. REMARK 100 THE DEPOSITION ID IS D_1000027783. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-MAR-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL32B2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : A FIXED EXIT SI DOUBLE CRYSTAL REMARK 200 MONOCHROMATOR FOLLOWED REMARK 200 BYSTANDARD DOUBLE CRYSTAL REMARK 200 MONOCHROMATOR AND RH-COATED REMARK 200 DOWNWARD-DEFLECTION MIRROR WITH REMARK 200 A TYPICAL GLANCING ANGLE OF REMARK 200 3.7MRAD REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS V REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53714 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 29.510 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.7 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.05900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.1 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : 0.22800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 2Z2L REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.74 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10-25% PEG4000, 0.2M AMMONIUM SULFATE, REMARK 280 0.1M SODIUM ACETATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 53.39450 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 85.95450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 53.39450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 85.95450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 16580 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 54660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -69.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 -88.66600 REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 71 REMARK 465 VAL A 72 REMARK 465 PRO A 73 REMARK 465 GLY A 232 REMARK 465 ILE A 233 REMARK 465 ILE A 234 REMARK 465 THR A 235 REMARK 465 TYR A 236 REMARK 465 GLU A 237 REMARK 465 LYS A 238 REMARK 465 LEU B 241 REMARK 465 GLY B 242 REMARK 465 ASN B 243 REMARK 465 ILE B 244 REMARK 465 VAL B 245 REMARK 465 PRO B 246 REMARK 465 GLY B 247 REMARK 465 THR B 248 REMARK 465 GLU B 249 REMARK 465 GLN B 250 REMARK 465 VAL B 251 REMARK 465 SER B 252 REMARK 465 GLN B 253 REMARK 465 LEU B 620 REMARK 465 GLN B 621 REMARK 465 THR B 622 REMARK 465 THR B 623 REMARK 465 ALA B 624 REMARK 465 LYS B 625 REMARK 465 THR D 71 REMARK 465 VAL D 72 REMARK 465 ASN D 103 REMARK 465 TYR D 104 REMARK 465 LYS D 105 REMARK 465 SER D 106 REMARK 465 ALA D 107 REMARK 465 THR D 108 REMARK 465 GLY D 109 REMARK 465 LYS D 110 REMARK 465 ILE D 111 REMARK 465 LEU D 112 REMARK 465 LEU D 170 REMARK 465 GLU D 171 REMARK 465 ALA D 172 REMARK 465 ALA D 173 REMARK 465 GLU D 174 REMARK 465 ILE D 233 REMARK 465 ILE D 234 REMARK 465 THR D 235 REMARK 465 TYR D 236 REMARK 465 GLU D 237 REMARK 465 LYS D 238 REMARK 465 LEU E 241 REMARK 465 GLY E 242 REMARK 465 ASN E 243 REMARK 465 ILE E 244 REMARK 465 VAL E 245 REMARK 465 PRO E 246 REMARK 465 GLY E 247 REMARK 465 THR E 248 REMARK 465 GLU E 249 REMARK 465 GLN E 250 REMARK 465 VAL E 251 REMARK 465 SER E 252 REMARK 465 GLN E 253 REMARK 465 GLN E 621 REMARK 465 THR E 622 REMARK 465 THR E 623 REMARK 465 ALA E 624 REMARK 465 LYS E 625 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 116 -7.91 -57.82 REMARK 500 PHE A 193 97.96 -166.62 REMARK 500 ALA A 194 42.09 38.99 REMARK 500 ASP A 208 33.77 -92.30 REMARK 500 LYS B 315 -5.63 73.89 REMARK 500 TRP B 324 56.23 -101.54 REMARK 500 ALA B 367 -113.80 44.53 REMARK 500 ASP B 431 40.05 71.72 REMARK 500 LYS B 496 150.35 -49.23 REMARK 500 HIS B 594 57.92 -144.33 REMARK 500 LEU B 618 -131.25 -134.27 REMARK 500 ASN C 735 3.95 85.63 REMARK 500 LYS D 116 -34.19 111.29 REMARK 500 ASN D 120 -44.57 74.65 REMARK 500 ASP D 131 76.76 51.61 REMARK 500 PHE D 151 23.39 -142.51 REMARK 500 ALA E 367 -116.44 48.20 REMARK 500 ASN E 377 15.03 57.80 REMARK 500 ASP E 471 26.33 45.17 REMARK 500 PRO E 540 127.70 -36.52 REMARK 500 LYS E 557 -70.86 -64.29 REMARK 500 LYS F 692 86.81 -160.46 REMARK 500 ASN F 715 88.84 63.11 REMARK 500 ASN F 735 0.63 94.14 REMARK 500 LYS F 742 -42.16 -142.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 E 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BMG B 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BMG E 801 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2ZC4 RELATED DB: PDB REMARK 900 RELATED ID: 2ZC5 RELATED DB: PDB REMARK 900 RELATED ID: 2ZC6 RELATED DB: PDB DBREF 2ZC3 A 71 238 UNP P59676 PBPX_STRR6 71 238 DBREF 2ZC3 B 241 625 UNP P59676 PBPX_STRR6 241 625 DBREF 2ZC3 C 626 750 UNP P59676 PBPX_STRR6 626 750 DBREF 2ZC3 D 71 238 UNP P59676 PBPX_STRR6 71 238 DBREF 2ZC3 E 241 625 UNP P59676 PBPX_STRR6 241 625 DBREF 2ZC3 F 626 750 UNP P59676 PBPX_STRR6 626 750 SEQRES 1 A 168 THR VAL PRO ALA LYS ARG GLY THR ILE TYR ASP ARG ASN SEQRES 2 A 168 GLY VAL PRO ILE ALA GLU ASP ALA THR SER TYR ASN VAL SEQRES 3 A 168 TYR ALA VAL ILE ASP GLU ASN TYR LYS SER ALA THR GLY SEQRES 4 A 168 LYS ILE LEU TYR VAL GLU LYS THR GLN PHE ASN LYS VAL SEQRES 5 A 168 ALA GLU VAL PHE HIS LYS TYR LEU ASP MET GLU GLU SER SEQRES 6 A 168 TYR VAL ARG GLU GLN LEU SER GLN PRO ASN LEU LYS GLN SEQRES 7 A 168 VAL SER PHE GLY ALA LYS GLY ASN GLY ILE THR TYR ALA SEQRES 8 A 168 ASN MET MET SER ILE LYS LYS GLU LEU GLU ALA ALA GLU SEQRES 9 A 168 VAL LYS GLY ILE ASP PHE THR THR SER PRO ASN ARG SER SEQRES 10 A 168 TYR PRO ASN GLY GLN PHE ALA SER SER PHE ILE GLY LEU SEQRES 11 A 168 ALA GLN LEU HIS GLU ASN GLU ASP GLY SER LYS SER LEU SEQRES 12 A 168 LEU GLY THR SER GLY MET GLU SER SER LEU ASN SER ILE SEQRES 13 A 168 LEU ALA GLY THR ASP GLY ILE ILE THR TYR GLU LYS SEQRES 1 B 385 LEU GLY ASN ILE VAL PRO GLY THR GLU GLN VAL SER GLN SEQRES 2 B 385 ARG THR MET ASP GLY LYS ASP VAL TYR THR THR ILE SER SEQRES 3 B 385 SER PRO LEU GLN SER PHE MET GLU THR GLN MET ASP ALA SEQRES 4 B 385 PHE GLN GLU LYS VAL LYS GLY LYS TYR MET THR ALA THR SEQRES 5 B 385 LEU VAL SER ALA LYS THR GLY GLU ILE LEU ALA THR THR SEQRES 6 B 385 GLN ARG PRO THR PHE ASP ALA ASP THR LYS GLU GLY ILE SEQRES 7 B 385 THR GLU ASP PHE VAL TRP ARG ASP ILE LEU TYR GLN SER SEQRES 8 B 385 ASN TYR GLU PRO GLY SER THR MET LYS VAL MET MET LEU SEQRES 9 B 385 ALA ALA ALA ILE ASP ASN ASN THR PHE PRO GLY GLY GLU SEQRES 10 B 385 VAL PHE ASN SER SER GLU LEU LYS ILE ALA ASP ALA THR SEQRES 11 B 385 ILE ARG ASP TRP ASP VAL ASN GLU GLY LEU THR GLY GLY SEQRES 12 B 385 ARG MET MET THR PHE SER GLN GLY PHE ALA HIS SER SER SEQRES 13 B 385 ASN VAL GLY MET THR LEU LEU GLU GLN LYS MET GLY ASP SEQRES 14 B 385 ALA THR TRP LEU ASP TYR LEU ASN ARG PHE LYS PHE GLY SEQRES 15 B 385 VAL PRO THR ARG PHE GLY LEU THR ASP GLU TYR ALA GLY SEQRES 16 B 385 GLN LEU PRO ALA ASP ASN ILE VAL ASN ILE ALA GLN SER SEQRES 17 B 385 SER PHE GLY GLN GLY ILE SER VAL THR GLN THR GLN MET SEQRES 18 B 385 ILE ARG ALA PHE THR ALA ILE ALA ASN ASP GLY VAL MET SEQRES 19 B 385 LEU GLU PRO LYS PHE ILE SER ALA ILE TYR ASP PRO ASN SEQRES 20 B 385 ASP GLN THR ALA ARG LYS SER GLN LYS GLU ILE VAL GLY SEQRES 21 B 385 ASN PRO VAL SER LYS ASP ALA ALA SER LEU THR ARG THR SEQRES 22 B 385 ASN MET VAL LEU VAL GLY THR ASP PRO VAL TYR GLY THR SEQRES 23 B 385 MET TYR ASN HIS SER THR GLY LYS PRO THR VAL THR VAL SEQRES 24 B 385 PRO GLY GLN ASN VAL ALA LEU LYS SER GLY THR ALA GLN SEQRES 25 B 385 ILE ALA ASP GLU LYS ASN GLY GLY TYR LEU VAL GLY LEU SEQRES 26 B 385 THR ASP TYR ILE PHE SER ALA VAL SER MET SER PRO ALA SEQRES 27 B 385 GLU ASN PRO ASP PHE ILE LEU TYR VAL THR VAL GLN GLN SEQRES 28 B 385 PRO GLU HIS TYR SER GLY ILE GLN LEU GLY GLU PHE ALA SEQRES 29 B 385 ASN PRO ILE LEU GLU ARG ALA SER ALA MET LYS ASP SER SEQRES 30 B 385 LEU ASN LEU GLN THR THR ALA LYS SEQRES 1 C 125 ALA LEU GLU GLN VAL SER GLN GLN SER PRO TYR PRO MET SEQRES 2 C 125 PRO SER VAL LYS ASP ILE SER PRO GLY ASP LEU ALA GLU SEQRES 3 C 125 GLU LEU ARG ARG ASN LEU VAL GLN PRO ILE VAL VAL GLY SEQRES 4 C 125 THR GLY THR LYS ILE LYS ASN SER SER ALA GLU GLU GLY SEQRES 5 C 125 LYS ASN LEU ALA PRO ASN GLN GLN VAL LEU ILE LEU SER SEQRES 6 C 125 ASP LYS ALA GLU GLU VAL PRO ASP MET TYR GLY TRP THR SEQRES 7 C 125 LYS GLU THR ALA GLU THR LEU ALA LYS TRP LEU ASN ILE SEQRES 8 C 125 GLU LEU GLU PHE GLN GLY SER GLY SER THR VAL GLN LYS SEQRES 9 C 125 GLN ASP VAL ARG ALA ASN THR ALA ILE LYS ASP ILE LYS SEQRES 10 C 125 LYS ILE THR LEU THR LEU GLY ASP SEQRES 1 D 168 THR VAL PRO ALA LYS ARG GLY THR ILE TYR ASP ARG ASN SEQRES 2 D 168 GLY VAL PRO ILE ALA GLU ASP ALA THR SER TYR ASN VAL SEQRES 3 D 168 TYR ALA VAL ILE ASP GLU ASN TYR LYS SER ALA THR GLY SEQRES 4 D 168 LYS ILE LEU TYR VAL GLU LYS THR GLN PHE ASN LYS VAL SEQRES 5 D 168 ALA GLU VAL PHE HIS LYS TYR LEU ASP MET GLU GLU SER SEQRES 6 D 168 TYR VAL ARG GLU GLN LEU SER GLN PRO ASN LEU LYS GLN SEQRES 7 D 168 VAL SER PHE GLY ALA LYS GLY ASN GLY ILE THR TYR ALA SEQRES 8 D 168 ASN MET MET SER ILE LYS LYS GLU LEU GLU ALA ALA GLU SEQRES 9 D 168 VAL LYS GLY ILE ASP PHE THR THR SER PRO ASN ARG SER SEQRES 10 D 168 TYR PRO ASN GLY GLN PHE ALA SER SER PHE ILE GLY LEU SEQRES 11 D 168 ALA GLN LEU HIS GLU ASN GLU ASP GLY SER LYS SER LEU SEQRES 12 D 168 LEU GLY THR SER GLY MET GLU SER SER LEU ASN SER ILE SEQRES 13 D 168 LEU ALA GLY THR ASP GLY ILE ILE THR TYR GLU LYS SEQRES 1 E 385 LEU GLY ASN ILE VAL PRO GLY THR GLU GLN VAL SER GLN SEQRES 2 E 385 ARG THR MET ASP GLY LYS ASP VAL TYR THR THR ILE SER SEQRES 3 E 385 SER PRO LEU GLN SER PHE MET GLU THR GLN MET ASP ALA SEQRES 4 E 385 PHE GLN GLU LYS VAL LYS GLY LYS TYR MET THR ALA THR SEQRES 5 E 385 LEU VAL SER ALA LYS THR GLY GLU ILE LEU ALA THR THR SEQRES 6 E 385 GLN ARG PRO THR PHE ASP ALA ASP THR LYS GLU GLY ILE SEQRES 7 E 385 THR GLU ASP PHE VAL TRP ARG ASP ILE LEU TYR GLN SER SEQRES 8 E 385 ASN TYR GLU PRO GLY SER THR MET LYS VAL MET MET LEU SEQRES 9 E 385 ALA ALA ALA ILE ASP ASN ASN THR PHE PRO GLY GLY GLU SEQRES 10 E 385 VAL PHE ASN SER SER GLU LEU LYS ILE ALA ASP ALA THR SEQRES 11 E 385 ILE ARG ASP TRP ASP VAL ASN GLU GLY LEU THR GLY GLY SEQRES 12 E 385 ARG MET MET THR PHE SER GLN GLY PHE ALA HIS SER SER SEQRES 13 E 385 ASN VAL GLY MET THR LEU LEU GLU GLN LYS MET GLY ASP SEQRES 14 E 385 ALA THR TRP LEU ASP TYR LEU ASN ARG PHE LYS PHE GLY SEQRES 15 E 385 VAL PRO THR ARG PHE GLY LEU THR ASP GLU TYR ALA GLY SEQRES 16 E 385 GLN LEU PRO ALA ASP ASN ILE VAL ASN ILE ALA GLN SER SEQRES 17 E 385 SER PHE GLY GLN GLY ILE SER VAL THR GLN THR GLN MET SEQRES 18 E 385 ILE ARG ALA PHE THR ALA ILE ALA ASN ASP GLY VAL MET SEQRES 19 E 385 LEU GLU PRO LYS PHE ILE SER ALA ILE TYR ASP PRO ASN SEQRES 20 E 385 ASP GLN THR ALA ARG LYS SER GLN LYS GLU ILE VAL GLY SEQRES 21 E 385 ASN PRO VAL SER LYS ASP ALA ALA SER LEU THR ARG THR SEQRES 22 E 385 ASN MET VAL LEU VAL GLY THR ASP PRO VAL TYR GLY THR SEQRES 23 E 385 MET TYR ASN HIS SER THR GLY LYS PRO THR VAL THR VAL SEQRES 24 E 385 PRO GLY GLN ASN VAL ALA LEU LYS SER GLY THR ALA GLN SEQRES 25 E 385 ILE ALA ASP GLU LYS ASN GLY GLY TYR LEU VAL GLY LEU SEQRES 26 E 385 THR ASP TYR ILE PHE SER ALA VAL SER MET SER PRO ALA SEQRES 27 E 385 GLU ASN PRO ASP PHE ILE LEU TYR VAL THR VAL GLN GLN SEQRES 28 E 385 PRO GLU HIS TYR SER GLY ILE GLN LEU GLY GLU PHE ALA SEQRES 29 E 385 ASN PRO ILE LEU GLU ARG ALA SER ALA MET LYS ASP SER SEQRES 30 E 385 LEU ASN LEU GLN THR THR ALA LYS SEQRES 1 F 125 ALA LEU GLU GLN VAL SER GLN GLN SER PRO TYR PRO MET SEQRES 2 F 125 PRO SER VAL LYS ASP ILE SER PRO GLY ASP LEU ALA GLU SEQRES 3 F 125 GLU LEU ARG ARG ASN LEU VAL GLN PRO ILE VAL VAL GLY SEQRES 4 F 125 THR GLY THR LYS ILE LYS ASN SER SER ALA GLU GLU GLY SEQRES 5 F 125 LYS ASN LEU ALA PRO ASN GLN GLN VAL LEU ILE LEU SER SEQRES 6 F 125 ASP LYS ALA GLU GLU VAL PRO ASP MET TYR GLY TRP THR SEQRES 7 F 125 LYS GLU THR ALA GLU THR LEU ALA LYS TRP LEU ASN ILE SEQRES 8 F 125 GLU LEU GLU PHE GLN GLY SER GLY SER THR VAL GLN LYS SEQRES 9 F 125 GLN ASP VAL ARG ALA ASN THR ALA ILE LYS ASP ILE LYS SEQRES 10 F 125 LYS ILE THR LEU THR LEU GLY ASP HET BMG B 801 24 HET SO4 E 901 5 HET BMG E 801 24 HETNAM BMG (4R,5S)-3-(6,7-DIHYDRO-5H-PYRAZOLO[1,2-A][1,2, HETNAM 2 BMG 4]TRIAZOL-4-IUM-6-YLSULFANYL)-5-[(1S,2R)-1-FORMYL-2- HETNAM 3 BMG HYDROXYPROPYL]-4-METH YL-4,5-DIHYDRO-1H-PYRROLE-2- HETNAM 4 BMG CARBOXYLATE HETNAM SO4 SULFATE ION HETSYN BMG (4R,5S)-3-(6,7-DIHYDRO-5H-PYRAZOLO[1,2-A][1,2, HETSYN 2 BMG 4]TRIAZOL-4-IUM-6-YLTHIO)-5-((2S,3R)-3-HYDROXY-1- HETSYN 3 BMG OXOBUTAN-2-YL)-4- METHYL-4,5-DIHYDRO-1H-PYRROLE-2- HETSYN 4 BMG CARBOXYLATE FORMUL 7 BMG 2(C15 H20 N4 O4 S) FORMUL 8 SO4 O4 S 2- FORMUL 10 HOH *82(H2 O) HELIX 1 1 GLN A 118 ASP A 131 1 14 HELIX 2 2 GLU A 133 SER A 142 1 10 HELIX 3 3 GLY A 152 ASN A 156 5 5 HELIX 4 4 THR A 159 GLU A 171 1 13 HELIX 5 5 ALA A 194 GLY A 199 1 6 HELIX 6 6 SER A 217 LEU A 223 1 7 HELIX 7 7 LEU A 223 ALA A 228 1 6 HELIX 8 8 SER B 266 LYS B 285 1 20 HELIX 9 9 PRO B 335 SER B 337 5 3 HELIX 10 10 THR B 338 ASN B 351 1 14 HELIX 11 11 ASP B 373 GLU B 378 1 6 HELIX 12 12 PHE B 388 SER B 395 1 8 HELIX 13 13 SER B 396 GLY B 408 1 13 HELIX 14 14 GLY B 408 PHE B 419 1 12 HELIX 15 15 ASN B 441 SER B 448 1 8 HELIX 16 16 SER B 449 GLY B 451 5 3 HELIX 17 17 THR B 457 ASN B 470 1 14 HELIX 18 18 SER B 504 ASP B 521 1 18 HELIX 19 19 SER B 596 MET B 614 1 19 HELIX 20 20 SER C 645 ASN C 656 1 12 HELIX 21 21 THR C 703 ASN C 715 1 13 HELIX 22 22 ASN D 120 TYR D 129 1 10 HELIX 23 23 GLU D 133 SER D 142 1 10 HELIX 24 24 GLY D 152 ASN D 156 5 5 HELIX 25 25 THR D 159 LYS D 168 1 10 HELIX 26 26 ALA D 194 GLY D 199 1 6 HELIX 27 27 SER D 217 LEU D 223 1 7 HELIX 28 28 LEU D 223 ALA D 228 1 6 HELIX 29 29 SER E 266 LYS E 285 1 20 HELIX 30 30 PRO E 335 THR E 338 5 4 HELIX 31 31 MET E 339 ASN E 350 1 12 HELIX 32 32 THR E 387 HIS E 394 1 8 HELIX 33 33 SER E 396 GLY E 408 1 13 HELIX 34 34 GLY E 408 PHE E 419 1 12 HELIX 35 35 ASN E 441 SER E 448 1 8 HELIX 36 36 SER E 449 GLY E 451 5 3 HELIX 37 37 THR E 457 ASN E 470 1 14 HELIX 38 38 SER E 504 ASP E 521 1 18 HELIX 39 39 SER E 596 MET E 614 1 19 HELIX 40 40 SER F 645 ASN F 656 1 12 HELIX 41 41 THR F 703 ASN F 715 1 13 SHEET 1 A 3 GLN A 148 SER A 150 0 SHEET 2 A 3 PRO A 86 VAL A 99 -1 N ALA A 98 O VAL A 149 SHEET 3 A 3 ILE A 178 SER A 187 -1 O SER A 187 N GLU A 89 SHEET 1 B 6 GLN A 148 SER A 150 0 SHEET 2 B 6 PRO A 86 VAL A 99 -1 N ALA A 98 O VAL A 149 SHEET 3 B 6 ILE A 79 TYR A 80 -1 N ILE A 79 O ILE A 87 SHEET 4 B 6 ASP B 260 THR B 263 1 O VAL B 261 N TYR A 80 SHEET 5 B 6 ILE B 480 TYR B 484 -1 O ALA B 482 N TYR B 262 SHEET 6 B 6 ALA B 491 LYS B 493 -1 O ARG B 492 N ILE B 483 SHEET 1 C 2 ALA A 201 ASN A 206 0 SHEET 2 C 2 SER A 210 GLY A 215 -1 O LEU A 214 N GLN A 202 SHEET 1 D 5 ILE B 301 ARG B 307 0 SHEET 2 D 5 TYR B 288 SER B 295 -1 N LEU B 293 O ALA B 303 SHEET 3 D 5 PHE B 583 GLN B 590 -1 O ILE B 584 N VAL B 294 SHEET 4 D 5 TYR B 568 SER B 576 -1 N PHE B 570 O VAL B 589 SHEET 5 D 5 ALA B 545 GLN B 552 -1 N ALA B 551 O ILE B 569 SHEET 1 E 2 VAL B 358 ASN B 360 0 SHEET 2 E 2 MET B 385 THR B 387 -1 O MET B 386 N PHE B 359 SHEET 1 F 2 LEU B 364 ILE B 366 0 SHEET 2 F 2 ALA B 369 ILE B 371 -1 O ALA B 369 N ILE B 366 SHEET 1 G 2 MET B 474 LEU B 475 0 SHEET 2 G 2 ILE B 498 GLY B 500 -1 O GLY B 500 N MET B 474 SHEET 1 H 3 GLN C 659 VAL C 663 0 SHEET 2 H 3 GLN C 685 SER C 690 1 O ILE C 688 N ILE C 661 SHEET 3 H 3 ILE C 669 SER C 672 -1 N LYS C 670 O LEU C 689 SHEET 1 I 3 GLU C 717 GLN C 721 0 SHEET 2 I 3 LYS C 743 GLY C 749 1 O LEU C 746 N GLU C 719 SHEET 3 I 3 THR C 726 GLN C 730 -1 N GLN C 728 O THR C 747 SHEET 1 J 6 ARG D 186 SER D 187 0 SHEET 2 J 6 PRO D 86 ASP D 90 -1 N GLU D 89 O SER D 187 SHEET 3 J 6 ILE D 79 TYR D 80 -1 N ILE D 79 O ILE D 87 SHEET 4 J 6 ASP E 260 THR E 263 1 O VAL E 261 N TYR D 80 SHEET 5 J 6 ILE E 480 ASP E 485 -1 O ALA E 482 N TYR E 262 SHEET 6 J 6 THR E 490 LYS E 493 -1 O THR E 490 N ASP E 485 SHEET 1 K 3 GLN D 148 VAL D 149 0 SHEET 2 K 3 SER D 93 VAL D 99 -1 N ALA D 98 O VAL D 149 SHEET 3 K 3 ILE D 178 SER D 183 -1 O SER D 183 N SER D 93 SHEET 1 L 2 ALA D 201 GLU D 205 0 SHEET 2 L 2 LYS D 211 GLY D 215 -1 O LEU D 214 N GLN D 202 SHEET 1 M 2 GLY D 229 THR D 230 0 SHEET 2 M 2 MET E 256 ASP E 257 -1 O MET E 256 N THR D 230 SHEET 1 N 5 ILE E 301 ARG E 307 0 SHEET 2 N 5 TYR E 288 SER E 295 -1 N LEU E 293 O ALA E 303 SHEET 3 N 5 PHE E 583 GLN E 590 -1 O ILE E 584 N VAL E 294 SHEET 4 N 5 TYR E 568 SER E 576 -1 N PHE E 570 O VAL E 589 SHEET 5 N 5 ALA E 545 GLN E 552 -1 N GLY E 549 O SER E 571 SHEET 1 O 2 LEU E 364 ILE E 366 0 SHEET 2 O 2 ALA E 369 ILE E 371 -1 O ILE E 371 N LEU E 364 SHEET 1 P 2 MET E 474 LEU E 475 0 SHEET 2 P 2 ILE E 498 GLY E 500 -1 O GLY E 500 N MET E 474 SHEET 1 Q 3 GLN F 659 VAL F 663 0 SHEET 2 Q 3 GLN F 685 SER F 690 1 O ILE F 688 N ILE F 661 SHEET 3 Q 3 ILE F 669 SER F 672 -1 N LYS F 670 O LEU F 689 SHEET 1 R 3 GLU F 717 GLY F 722 0 SHEET 2 R 3 LYS F 743 GLY F 749 1 O ILE F 744 N GLU F 717 SHEET 3 R 3 THR F 726 GLN F 730 -1 N THR F 726 O GLY F 749 LINK OG SER B 337 C7 BMG B 801 1555 1555 1.37 LINK OG SER E 337 C7 BMG E 801 1555 1555 1.37 CISPEP 1 ARG B 307 PRO B 308 0 -0.91 CISPEP 2 SER B 576 PRO B 577 0 -11.33 CISPEP 3 ARG E 307 PRO E 308 0 0.62 CISPEP 4 SER E 576 PRO E 577 0 -5.38 SITE 1 AC1 3 THR E 425 ARG E 426 ARG F 654 SITE 1 AC2 12 SER B 337 TRP B 374 SER B 395 ASN B 397 SITE 2 AC2 12 PHE B 450 THR B 526 LYS B 547 SER B 548 SITE 3 AC2 12 GLY B 549 THR B 550 LEU D 203 LYS D 211 SITE 1 AC3 10 GLU B 320 SER E 337 TRP E 374 SER E 395 SITE 2 AC3 10 ASN E 397 GLN E 452 LYS E 547 SER E 548 SITE 3 AC3 10 GLY E 549 THR E 550 CRYST1 106.789 171.909 88.666 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009364 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005817 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011278 0.00000